DESIGNER DRUGS: A BRIEF HISTORY OF THE ATTEMPT TO SYSTEMIZE ON THE EXAMPLES OF “SPICE” AND “SALTS”

Vladimir V Mrykhin; Andrei V Antsyborov

doi:10.17816/nb14061

Neurology Bulletin ›› 2017, Vol. XLIX ›› Issue (1) : 97 -100. DOI: 10.17816/nb14061

Articles

brief-report

DESIGNER DRUGS: A BRIEF HISTORY OF THE ATTEMPT TO SYSTEMIZE ON THE EXAMPLES OF “SPICE” AND “SALTS”

Author information +

History +

PDF

Abstract

On the basis of domestic and international literature data there was analyzed chemical structure of drugs-synthetic cathinones (“salts”) and synthetic cannabinoids (“spice”)there were also reviewed the psychoactive effects of these substances on the body, the ability to produce mental, somatic and neurological disorders.

Keywords

designer drugs / synthetic cathinones / synthetic cannabinoids / chemical structure / effects on the body / review

Cite this article

Download citation ▾

Vladimir V Mrykhin, Andrei V Antsyborov. DESIGNER DRUGS: A BRIEF HISTORY OF THE ATTEMPT TO SYSTEMIZE ON THE EXAMPLES OF “SPICE” AND “SALTS”. Neurology Bulletin, 2017, XLIX(1): 97-100 DOI:10.17816/nb14061

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Головко А.И., Софронов А.Г., Софронов Г.А. «Новые» запрещенные каннабиноиды. Нейрохимия и нейробиология // Наркология. 2010. № 7. С. 68-83.

[2]	Митин А.В. Исследование курительных ароматических смесей // Судебная экспертиза. 2010. № 1. С. 30-39.

[3]	Головко А.И., Баринов В.А., Бонитенко Е.Ю. и др. Токсикологическая характеристика дизайнерских наркотиков. www.medline.ru. Т.16. Токсикология, 20 января 2015. Ст.4. С. 26-57.

[4]	Менделевич В.Д. Психотические расстройства в результате употребления наркотиков: Современное состояние проблемы // Наркология. 2014. № 7. С. 93-100.

[5]	Moore T.H., Zammit S., Lingford-Hughes A. et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review // Lancet. 2007. Vol. 370, № 9584. P. 319-328.

[6]	Müller H., Sperling W., Köhrmann M. et al. The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes // Schizophr. Res. 2010. Vol. 118, № 1-3. P. 309-310.

[7]	Müller-Vahl K.R., Emrich H.M. Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia // Expert Rev. Neurother. 2008. Vol. 8, № 7. P. 1037-1048.

[8]	Schneir A.B., Cullen J., Ly B.T. «Spice» girls: synthetic cannabinoid intoxication // J. Emerg. Med. 2011. Vol. 40, № 3. P. 296-299.

[9]	Van der Veer N., Friday J. Persistent psychosis following the use of Spice // Schizophr. Res. 2011. Vol. 130, № 1-3. P. 285-286.

[10]	Karch’s Pathology of Drug Abuse. Fifth Edition. 2016 by Taylor & Francis Group, LLC CRC. Press is an imprint of Taylor & Francis Group, an Informa business

[11]	Winstock A.R., Mitcheson L.R., Deluca P. et al. Mephedrone, new kid for the chop? // Addiction 2011. Vol. 106(1). P. 154-161.

[12]	Zimmermann U.S., Winkelmann P.R., Pilhatsch M. et al. Withdrawal phenomena and dependence syndrome after the consumption of “spice gold” // Dtsch. Arztebl. Int. 2009. Vol. 106, № 27. P. 464-467.